HLA-SE等位基因与ACPA-IgG可变域糖基化在类风湿关节炎发病前期的存在
该研究在症状前个体与RA患者的配对样本中分析ACPA-IgG可变域糖基化,发现V域糖基化在发病前最多15年即已存在且随症状临近而增加,HLA-SE等位基因与V域糖基化存在关联。
要点
- ACPA-IgG可变域糖基化在RA症状出现前最多15年即可检出。
- V域糖基化丰度随接近症状发作而增加。
- HLA-SE等位基因与症状前ACPA-IgG V域糖基化相关。
核心结论
- ACPA的体细胞超突变导致N连接糖基化位点引入及V域糖基化,在将发展为RA的个体中于症状发作前数年即已发生。
- HLA-SE等位基因在疾病前期与ACPA-IgG V域糖基化相关,进一步细化了HLA-SE与ACPA阳性RA发展之间的联系。
研究设计与样本
- 使用超高效液相色谱(UHPLC)分析症状前个体与RA患者配对样本中的ACPA-IgG V域糖基化。
- 症状前个体n=201(139例ACPA阳性、62例ACPA阴性),症状前时间中位数(IQR)为5.8(5.9)年;RA患者n=99(94例ACPA阳性、5例ACPA阴性)。
主要发现
- 症状前个体中ACPA-IgG V域糖基化在疾病发生前最多15年即已存在。
- V域糖基化丰度随接近症状发作而增加。
- HLA-SE等位基因与ACPA-IgG V域糖基化的存在相关。
临床怎么用
- 在RA高风险个体中,ACPA-IgG V域糖基化可作为症状前阶段的免疫学标志物进行探索。
- HLA-SE等位基因与V域糖基化的关联提示可结合遗传背景评估ACPA阳性个体的发病风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis (RA) patients display a unique feature defined by the abundant presence of N-linked glycans within the variable domains (V-domains). Recently, we showed that N-glycosylation sites, which are required for the incorporation of V-domain glycans, are introduced following somatic hypermutation. However, it is currently unclear when V-domain glycosylation occurs. Further, it is unknown which factors might trigger the generation of V-domain glycans and whether such glycans are relevant for the transition towards RA. Here, we determined the presence of ACPA-IgG V-domain glycans in paired samples of pre-symptomatic individuals and RA patients. METHODS: ACPA-IgG V-domain glycosylation was analysed using ultra-high performance liquid chromatography (UHPLC) in paired samples of pre-symptomatic individuals (median interquartile range (IQR) pre-dating time: 5.8 (5.9) years; n=201; 139 ACPA-positive and 62 ACPA-negative) and RA patients (n=99; 94 ACPA-positive and 5 ACPA-negative). RESULTS: V-domain glycans on ACPA-IgG were already present up to 15 years before disease in pre-symptomatic individuals and their abundance increased closer to symptom onset. Noteworthy, human leucocyte antigen class II shared epitope (HLA-SE) alleles associated with the presence of V-domain glycans on ACPA-IgG. CONCLUSION: Our observations indicate that somatic hypermutation of ACPA, which results in the incorporation of N-linked glycosylation sites and consequently V-domain glycans, occurs already years before symptom onset in individuals that will develop RA later in life. Moreover, our findings provide first evidence that HLA-SE alleles associate with ACPA-IgG V-domain glycosylation in the pre-disease phase and thereby further refine the connection between HLA-SE and the development of ACPA-positive RA.
引用
- Kissel T, van Schie KA, Hafkenscheid L, et al. On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis. Ann Rheum Dis. 2019. PMID: 31471298. doi:10.1136/annrheumdis-2019-215698
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。